Short-Term Debt to Capital: Elutia Inc (ELUT)

The current market quotes for Elutia Inc. (ELUT) visualized below demonstrate the dynamics of a company with a metric of 0.39. The firm maintains a stable cash flow through the sale of protective implant envelopes. The business relies on partnerships with clinics to create anti-infective agents for cardiac surgery, while low dependence on economic cycles ensures resilient demand for consumables.

For Elutia Inc. (ELUT), which operates in the defensive regenerative medicine sector, the short-term debt-to-equity ratio serves as an indicator of financial stability amid stable hospital demand. This trend captures the proportion of liabilities with a maturity of over one year relative to equity, where a sharp spike on the chart signals capacity expansion while simultaneously increasing the risk of cash flow gaps.